Log in to your Inderes Free account to see all free content on this page.
Devyser Diagnostics
79.20 SEK
-0.50 %
Less than 1K followers
DVYSR
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Devyser Diagnostics
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 48.7 | 64.3 | 216.9 | 54.8 | 67.4 | 56.4 | 72.0 | 250.5 |
| EBITDA | -16.7 | -12.4 | -51.0 | -13.9 | 5.5 | 8.1 | 37.5 | 37.2 |
| EBIT | -23.7 | 0.7 | -58.3 | -20.5 | 5.5 | 1.3 | 18.0 | 10.1 |
| EBIT-% | -48.7 % | 1.1 % | -26.9 % | -37.4 % | 8.2 % | 2.3 % | 25.0 % | 4.0 % |
| Profit before taxes | -23.5 | -0.6 | -57.6 | -20.9 | 2.0 | 0.2 | 16.0 | -2.6 |
| Net income | -23.2 | -3.2 | -61.5 | -20.5 | 1.3 | -2.8 | 13.6 | -8.4 |
Login required
This content is only available for logged in users